Boc-1-aminocyclopentane-1-carboxy acid

Boc-1-aminocyclopentane-1-carboxy acid is a Boc-protected cyclic amino acid building block featuring a cyclopentane ring that enforces conformational constraint while retaining the amino acid backbone functionality for peptide assembly. The tert-butoxycarbonyl (Boc) group on the amino terminus makes it a protected amino acid suitable for controlled coupling workflows and downstream deprotection strategies used in peptide and peptidomimetic synthesis. Its rigid, bulky side-chain environment is frequently leveraged to probe structure-activity relationships and to introduce non-standard stereoelectronic features into synthetic sequences.

1. Peptidomimetic Building Block

Boc-1-aminocyclopentane-1-carboxy acid is used by peptide chemistry groups and medicinal chemistry teams to incorporate a conformationally restricted cyclic residue into peptidomimetics and backbone-modified analogs. The cyclopentane side-chain provides steric and conformational bias relative to acyclic amino acids, which is valuable when optimizing helix propensity, turn formation, or local geometry in SAR studies. Researchers typically select this protected amino acid when they need a stable, isolable building block that can be handled through standard protected-amino-acid coupling and deprotection sequences to generate defined, sequence-specific analogs.

2. Protected Amino Acid Intermediate

Boc-1-aminocyclopentane-1-carboxy acid serves as a practical intermediate for custom peptide manufacturing and research-scale synthesis where a Boc-protected cyclic amino acid is required as an input material. Its protected amine functionality supports controlled assembly of longer peptide segments or specialized fragments, enabling reproducible incorporation of the cyclopentane-bearing residue into target constructs. Pharmaceutical intermediate development teams often rely on this type of building block to streamline procurement of a specific, structurally defined amino acid unit for library synthesis and analog generation, especially when the cyclic scaffold is central to the design rationale.

3. Conformational Constraint Studies

Boc-1-aminocyclopentane-1-carboxy acid is frequently selected for chemical biology and protein/peptide interaction studies that aim to understand how backbone rigidity influences binding conformations and recognition patterns. By introducing a cyclopentane-containing residue, researchers can create analog series that systematically vary conformational freedom while keeping other sequence elements constant, supporting structure-function analysis in synthetic receptor/ligand systems. This building block is particularly relevant for generating well-defined, sequence-resolved compounds used in biophysical characterization workflows where consistent stereochemical and structural features are critical for interpreting observed trends.

4. Peptide Fragment Synthesis

Boc-1-aminocyclopentane-1-carboxy acid is also used to prepare peptide fragments and modified segments that contain a single cyclic residue as a defined junction point within a larger construct. In custom synthesis environments, the Boc protection pattern helps manage chemoselectivity during stepwise assembly, supporting the preparation of intermediate sequences that can be condensed further to yield full-length peptides or peptide-like molecules. Such fragment-based workflows are common in research groups building libraries of analogs, where rapid and reliable incorporation of a specific cyclic amino acid unit improves reproducibility across parallel synthesis campaigns.

1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

3. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

4. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

5. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction